M1 Kliniken AG
MKLNF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Revenue | $184 | $171 | $168 | $166 |
| % Growth | 7.1% | 2.2% | 1.3% | – |
| Cost of Goods Sold | $159 | $131 | $145 | $149 |
| Gross Profit | $24 | $41 | $23 | $17 |
| % Margin | 13.3% | 23.9% | 13.5% | 10.2% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $3 | $0 | $0 |
| SG&A Expenses | $6 | $7 | $0 | $2 |
| Sales & Mktg Exp. | $0 | $5 | $0 | $0 |
| Other Operating Expenses | -$0 | $21 | $8 | $6 |
| Operating Expenses | $6 | $29 | $8 | $8 |
| Operating Income | $18 | $12 | $14 | $8 |
| % Margin | 9.8% | 7.2% | 8.6% | 5.1% |
| Other Income/Exp. Net | -$1 | -$1 | $1 | $1 |
| Pre-Tax Income | $17 | $11 | $15 | $9 |
| Tax Expense | $4 | $4 | $4 | $2 |
| Net Income | $12 | $6 | $10 | $7 |
| % Margin | 6.3% | 3.6% | 5.9% | 4.1% |
| EPS | 0.63 | 0.33 | 0.53 | 0.38 |
| % Growth | 90.9% | -37.7% | 39.5% | – |
| EPS Diluted | 0.63 | 0.29 | 0.53 | 0.38 |
| Weighted Avg Shares Out | 19 | 19 | 19 | 18 |
| Weighted Avg Shares Out Dil | 19 | 20 | 19 | 18 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1 | $1 | $0 | $1 |
| Interest Expense | $1 | $2 | $0 | $0 |
| Depreciation & Amortization | $3 | $3 | $2 | $1 |
| EBITDA | $20 | $16 | $17 | $8 |
| % Margin | 11% | 9.6% | 10.1% | 4.8% |